Hana Jin

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Radiation Therapy

Polycystic Ovary Syndrome

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Hoon Sik Choi, Young Shin Ko, Hana Jin, Ki Mun Kang, In Bong Ha, Hojin Jeong, Jeong Hee Lee, Bae Kwon Jeong, Hye Jung Kim
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity. International journal of molecular sciences 23 (24) (2022)
Hana Jin, Hye Jung Kim
P2Y 2 R-Mediated PAK1 Activation Is Involved in ESM-1 Overexpression in RT-R-MDA-MB-231 through FoxO1 Regulation. Cancers 14 (17) (2022)
Hoon Sik Choi, Young Shin Ko, Hana Jin, Ki Mun Kang, In Bong Ha, Hojin Jeong, Jeong Hee Lee, Bae Kwon Jeong, Hye Jung Kim
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity. International journal of molecular sciences 23 (24) (2022)
Hoon Sik Choi, Young Shin Ko, Hana Jin, Ki Mun Kang, In Bong Ha, Hojin Jeong, Jeong Hee Lee, Bae Kwon Jeong, Hye Jung Kim
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity. International journal of molecular sciences 23 (24) (2022)